Is Aminophylline registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Aminophylline, including AMINOPHYLLINE INJ 250MG (25 mg/ml, Injection, SAR 4.15).

Is Aminophylline approved by the US FDA?

Drugs@FDA lists 66 application product lines for Aminophylline, including AMINOPHYLLINE (Prescription); AMINOPHYLLIN (Discontinued); AMINOPHYLLINE (Discontinued); AMINOPHYLLINE (Discontinued); AMINOPHYLLINE (Discontinued).

Active substance

Aminophylline

SFDA 3
US FDA 66
Health Canada 1
NHS prices 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
AMINOPHYLLINE INJ 250MG	25 mg/ml	Injection · Intravenous use	1 Vial	SAR 4.15	NCE · Prescription	HOSPIRA INC	Valid
AMINOPHYLLINE 250 Mg Injection*	25 mg/ml	Injection · Intravenous use	10 Ampoule	SAR 15.40	Generic · Prescription	ANTIGEN	Withdrawn by MAH · Not Marketed
NEOPHYLLIN TAB 100MG	100 mg	Tablet · Oral use	100 Tablet Container	SAR 16.50	NCE · Prescription	EISAI	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

ANESTHESIA-SUPPORTIVE AGENTS/ ANAPHYLACTIC REACTIONS; BRADYCARDIA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
AMINOPHYLLINE	25MG/ML	injectable · injection	HOSPIRA	Prescription	26 Oct 1983
AMINOPHYLLIN	100MG; 200MG	tablet · oral	GD SEARLE LLC	Discontinued	19 Apr 1940
AMINOPHYLLINE	100MG	tablet · oral	HIKMA INTL PHARMS	Discontinued	26 Nov 1975
AMINOPHYLLINE	100MG; 200MG	tablet · oral	CHARTWELL MOLECULAR	Discontinued	17 Dec 1975
AMINOPHYLLINE	100MG	tablet, delayed release · oral	IMPAX LABS	Discontinued	16 Mar 1976
AMINOPHYLLINE	200MG	tablet, delayed release · oral	IMPAX LABS	Discontinued	19 Mar 1976
AMINOPHYLLINE	200MG	tablet · oral	VALEANT PHARM INTL	Discontinued	28 May 1976
AMINOPHYLLINE	200MG	tablet · oral	HIKMA INTL PHARMS	Discontinued	28 May 1976
AMINOPHYLLINE	100MG	tablet · oral	HALSEY	Discontinued	15 Jun 1976
AMINOPHYLLINE	100MG	tablet · oral	KV PHARM	Discontinued	27 Oct 1976
AMINOPHYLLINE	200MG	tablet · oral	KV PHARM	Discontinued	29 Oct 1976
AMINOPHYLLINE	200MG; 100MG	tablet · oral	ANI PHARMS	Discontinued	22 Dec 1976
PHYLLOCONTIN	225MG	tablet, extended release · oral	PHARM RES ASSOC	Discontinued	21 Nov 1979
SOMOPHYLLIN-DF	105MG/5ML	solution · oral	FISONS	Discontinued	30 Sep 1980
AMINOPHYLLINE	25MG/ML	injectable · injection	ELKINS SINN	Discontinued	11 Feb 1981
AMINOPHYLLINE	25MG/ML	injectable · injection	LUITPOLD	Discontinued	16 Apr 1981
AMINOPHYLLINE	25MG/ML	injectable · injection	AM REGENT	Discontinued	27 Aug 1981
AMINOPHYLLINE	25MG/ML	injectable · injection	LYPHOMED	Discontinued	10 Nov 1981
AMINOPHYLLINE	25MG/ML	injectable · injection	INTL MEDICATION	Discontinued	1 Feb 1982
AMINOPHYLLINE	100MG	tablet · oral	ROXANE	Discontinued	9 Feb 1982
AMINOPHYLLINE	200MG	tablet · oral	ROXANE	Discontinued	9 Feb 1982
AMINOPHYLLINE DYE FREE	105MG/5ML	solution · oral	ACTAVIS MID ATLANTIC	Discontinued	16 Apr 1982
AMINOPHYLLIN	25MG/ML	injectable · injection	GD SEARLE LLC	Discontinued	24 May 1982
AMINOPHYLLINE	25MG/ML	injectable · injection	HOSPIRA	Discontinued	23 Jul 1982
TRUPHYLLINE	250MG; 500MG	suppository · rectal	COSETTE PHARMS NC	Discontinued	3 Jan 1983

41 more — full table

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
AMINOPHYLLINE INJ 25MG/ML	00582662	25 MG / ML	SOLUTION · INTRAVENOUS	OMEGA LABORATORIES LIMITED

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
NHS Drug Tariff	Aminophylline 250mg/10ml solution for injection ampoules	£15.00	10 ampoule	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.